amikacin has been researched along with Urinary Bladder, Neurogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amasyali, AS; Erol, H; Kucukdurmaz, F; Sonmez, F; Yilmaz, D; Yilmaz, M | 1 |
| Jimenez, EM; Lindquist, LB; Montgomerie, JZ; Morrow, JW; Sapico, FL | 1 |
| Iwao, N; Konya, H; Kuroda, J; Morita, M | 1 |
1 trial(s) available for amikacin and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Humans; Injections, Intramuscular; Kanamycin; Proteus Infections; Providencia; Pseudomonas Infections; Random Allocation; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1980 |
2 other study(ies) available for amikacin and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Management of urinary tract infection with intravesical amikacin may increase the risk of bladder oxidative stress in children with neurogenic bladder.
Topics: Administration, Intravesical; Amikacin; Anti-Bacterial Agents; Biomarkers; Child; Child, Preschool; Female; Glutathione; Humans; Male; Oxidative Stress; Prospective Studies; Urinary Bladder, Neurogenic; Urinary Tract Infections | 2017 |
[Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
Topics: Adult; Aged; Amikacin; Chronic Disease; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1978 |